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???????. ???????-?????????????????? ?????????????? ???????????? ??????? ????, ?????????????
? ?????? ??????? ? ???????????? ???????? ?????????? ??????????? ?????. ???????? ?.?. ?????
???????????? ???? ????????? ???????-?????????????????? ????????????? ??????? ????, ???????????? ??
??????? ???????????? ?????????? ? ??????????? ? ??????? ?, ?, ?, D ?? ????????????? GOLD, 2011. ?????-
?????? 112 ???????????? ??????? ???? ? ???? ????????. ? ???? ????????? ???????????????? ???????-
??????????? ??????, ????????????? ?????? ????? ????, ???????? ??????????? ???????, ??????????? ??????
?? ????? mMRC, ??????????? ???????????. ????????????, ??? ???????????? ??????? ? ???? – ???
??????????? ??????, ? ??????? ??????????? ?????????? ???? ? ????????? (48,22 %) ? ??????? (30,36 %) 
??????????? ??????????? ?????. ???????? ?? ??????????? ??????????? ?????? ????? ????????????
???????, ???????????, ??? ??????? ?????? ?????????? (? = 0,002) ???? ????? ????????? ? ?????? ?
????????? ??????????? (22,58±5,31 %) ?? ????????? ? ?????? ? ??????? ??? ????? ??????? ????????
??????????? ?????????? ?????? ? ??????????? ????? (6,00±3,36 %). ??????? ? ??????? ? ????? ???????
??????????? ????? ?????????? ??????? ??????? (? = 0,024). ? ?? ?? ????? ??? ????????????? ????????? ??
????????????? GOLD, 2011, ??? ?????? ??????? ?? ?????????? ?? ?? ?????? ?? ??????????????????
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???????????, ? ??? ????? ?? ???? ? ?? ???????? (? > 0,050). ????????????? ??????? ?? ??????? ????? ???????
?????????? ?? ???????? ?????????? ?????????? ???????? ? ???????????? ?? ???????? ??????????
??????????? ?????. ?????? ?????? (50,00±4,43 % ???????) ??????? ?????? ? ?????? ? ? ?????? ???????
(10,20±4,32 %) ????????? ? ?????? D ?? ?? ??????? ????????????????, ? ?? ?????????? ?????????? ? ???????
???????? ????. ??????? ? ?????????? ????????????? ????????????? ????????????? ????? ????????? ????-
????????? ???????.
Abstract. Clinical-anthropometric characteristics of COPD outpatients belonging to the different groups and 
having different severity of airway obstruction. Gashynova K.Y. The aim of the study was to compare the clinical 
and anthropometric characteristics of patients with COPD, which differ in the degree of airways obstruction and 
belong to groups A, B, C, D in accordance with GOLD, 2011 classification. A total of 112 ambulatory COPD patients 
in remission made the study sample. Anthropometric data, body mass index, medical history, dyspnea by mMRC scale, 
and spirometry was performed for all patients. There was confirmed that outpatients with COPD is a heterogeneous 
group, in which the majority are those with moderate (48.22 %) and severe (30.36 %), airway obstruction. Despite the 
vast majority of men among outpatients, the percentage of women among patients with mild to moderate obstruction 
(22.58±5.31 %) was significantly higher (p=0.002) as compared with those with severe or very severe limitation of 
airflow (6.00±3.36 %). Patients with severe and very severe obstruction were of significantly older age (p = 0.024). At 
the same time, the distribution of patients according to the GOLD, 2011 classification, demonstrate that all groups did 
not differ on any of the anthropometric indicators, including gender and age (p > 0.050). Distribution of patients by 
groups with different risk for future exacerbations is not a mirror image of gradation in accordance with the degree of 
airway obstruction. Every second (50.00±4.43 % of cases) patient is included in group C and every tenth 
(10.20±4.32 %) belongs to the group D not due to degree of bronchial obstruction, but due to the number of exa-
cerbations in the past year. Therefore, in future studies it is advisable to use both principles of patients’ classification. 
?????????? ???????? ?????????? ???????????,
?? ???????? ? ???? ? ??????????? ????????
????????? ??????????? ?????? ????????????? ??
?????????? ????????????????, ???????? ??-
????????, ????????????? ?? ???????? ?????-
??????, ?????????????? ?? ????????? ??????-
?????? [5, 6, 8]. ???? ? ???? ???????? ?????????
?????????? ?????????? ? ??????????? ?? ?????????
???? (GOLD) ? ?????? ???????????? ????
????????? ????????????????? ?????? ?????
??????? ? ??????????? ?? ?????? ??????????
??????? ??????????? ??????? (???), ??? ?
?????????? ????????? ????????????, ? ?????
??????????? ????????? ??????? ?? ????????
????????? ?????????? ??/??? ????????? ?????-
????????? ????? ??????????? ???? ????????
???????? ???? [12]. ??????????? ?????? ???
?????????????? ? ? ?????? ? 555 ????????????
??????? ??????'? ??????? ??? 27 ?????? 2013 
???? [3]. ????, ?????????? ??????????, ?? ???-
?????? ?? ?????????? ???, ???????? ????????????
????????? ????? ???????????? ??? ?????????????
???????? ???? ?? ? ???????????? [7, 9, 10, 11, 
13]. ???? ?????????? ?????????? ?????? ??????-
?????? ??? ???????, ?? ???? ??????????? ????
?? ???????? ????????? ??????????? ?????? ?
????????? ??????, ? ????, ??? ??? ?????????? ??
?????? ????????? ?? ?????????? ????? ???-
?????????.
????? ??????????? ???? ?????????? ???????-
???????????????? ????????????? ?????? ??
????, ?? ???????????? ?? ???????? ????????????
??????????, ?? ?????????, ??? ???????? ?? ???? ?,
?, ?, D ?????? ? ????????????? GOLD, 2011. 
????????? ?? ?????? ??????????
? ??????????? ???? ???????? ???????????
????? ?? ???? ? ???? ???????, ??? ?????????
??????? ?????????? ? ????????????? ??????-
???????? ?????? «?????» ??? ????????????
??????? «???????????????? ????? ?????? ????????
???????» ????????????????? ???????? ????» ?
2007 ?? 2014 ???. ? ???? ????????? ?????????????
??????????????? ???? (?????, ???, ?????, ????), 
?????????????? ?????? ???? ???? (???), ????????
???????? ??????? (?????????? ???????????? ?
??????? ?????? ????????????????? ???????? ??
????????? ?????????? ???????? ???????? ????),
??????????? ??????? ?? ????????????? ??????
??????????? ???????? ???? (mMRC) [12]. ????
?????? ??????????? ??????????? ?? ?????????
?????????? MasterLab (Viasis, ?????????) ?
??????? ????-?????????????????? ??????? ??’?-
?? ??????????? ?????? ?? ????? ???????
(???1), ?????????? ???????? ??????? ??????
(????), ?? ?????????????? ???1/???? [1, 
14]. ??????????, ?? ????????, ???? ????????? ??
????????????? ???????? ?? ??????????? ??????-
???? ?? ????????? ???????? «STATISTICA 6.1» 
(StatSoft Inc., USA, ???????? ? AGAR909 
E415822FA) [2, 4]. 
?????????? ?? ?? ???????????
? ??????????? ???? ???????? 112 ??????.
????? ??? ???? 17 (15,18±3,39 %) ????? ??
???????? ????????
??????? ???????????38
95 ????????? (84,82±3,39 %), ??? ?????? ???????-
?? (p < 0,001) ?????????. ???????? ??? ????????
60,80±9,52 ????, ????? ?????????? 173,00 [168,00-
178,00] ??, ???? – 79,50 [69,00-94,30] ??, ????
???????????? ???????? 9,00 [3,00-17,00] ?????.
?????????? ????????????? ??? ?????????????
??????? ? ????? ????????? ???????? ????-
???????? ??????????, ??? ?????? ?? ???? ??????,
????? ???????? ?????? ????????????????. ???-
??????, ???????? ????? ?????? ????? ? ??????
???????? ????????? ??????????? ?????? (8 ????,
7,14±2,43 %), ???????? ???? ???????? ???????????
????? ??????????? ?? ???????? ?????????, ????
?? ??? ?????? ?? ????? ?????????, ??? ??
???????? ?? ?????????. ????? ? ??????????, ??
???? ? ???? ?????? ?????????? ???????????
?????? ??? ???? ?? ???? ?????? (???? 16, 
14,28±3,31 %), ????, ????????, ???? ????? ?? ?
??????? ????????????? ???????????? ????????
???????, ???, ???????, ????? ?????? ????. ???-
???????????? ? ??????? ???? ????? ? ????????
(54 ?????, 48,22±4,72 %) ?? ?????? (34 ?????,
30,36±4,34 %) ??????????? ????????? ??????.
????? ???????? ????????? ????????????? ? ??????
?? ???????? ???????? ? ???? ????????? ?????-
?????? ????????? ???? ? ?????? ?? ???? ??????
???????????? ??????????? (? = 0,109). ???? ???-
???? ???????????????? ????????????? ?????? ?
?????? ???????? ???????????? ?????????? ??-
?????? ? ??????? 1. 
? ? ? ? ? ? ?  1  
??????????????? ???? ???????????? ?????? ?? ????
? ?????? ???????? ???????? ???????????? ??????????
????????? ?????? (?)(n = 8) 
???????? (??)
(n = 54) 
??????(???)
(n = 34) 
???? ?????? (?V)
(n = 16) 
?????:
1) ????????, n (?±m %) 

















































?????? ? ?????????? ??????, ? ????????? ?
?????? ???????? ???????? ?????????? ?? ????
??????????? ???????? ???????????? ?? ???????
(? = 0,175), ????? ???? (? = 0,151) ?? ???
(? = 0,651). ????? ????? ?? ???????????? ?? ???-
??? ???????????? (? = 0,065). ??? ????? ?
?????? ?? ???? ?????? ??????????? ???? ??-
???????? ????????? (? = 0,024). ????? ?????????
????? ??? ????, ??, ?????????? ?? ?????????
????????? ????????? ? ???? ??????, ???????? ?????
??? ?????????? (? = 0,002) ??????? ????? ??????
? ?????? ?? ???????? ??????????? (22,58±5,31 %) 
????????? ? ??????? ? ?????? ??? ???? ??????
???????? ????????? ??????????? ?????? ?
????????? ?????? (6,00±3,36 %). 
??????? ???????????? ????????? ?????? ?
?????????? GOLD, 2011 ???? ???????????? ???
??????????? ???????? ?? ????????? ????????????
??????????. ???, ????? ??????? ?????????????
(34 ?????, 30,36±4,34 %) ???????? ?? ????? ?,
????? ??? ?????? ??? ???????? ?????????? ????
?????????? ???????? ???????????? ?? ??
????????? ?? ????? ???????????. ??? ?? ?????
?????????? ???? ????? ????? D (49 ????,
43,75±4,69), ??? ??? ?????? ??? ???? ??????
?????????? ???? ??????? ????? ??????????? ??
?????? ???????? ??????. ????? ????????????? ?
??????? ??????, ??? ???? ???????? ? ???????????,
????????? ???????????? ?????????? ???? ??-
???????. ? ??? ?? ??? ????? B ? C (17 
(15,18±3,39 %) ?? 12 (10,71±2,92 %) ???? ?????-
?????), ??? ???? ????????? ??????????
(? = 0,319), ????????? ?????? (? < 0,050) ?????-
?? ????????? ? ??????? ? ??? D, ???? ? ????
????????? ?????? ???? B ? C ????????? ?????? ???
?????? ???? ????, ??? ??????????? ??? ??????-
????????. ????, ??????? ??????????? ???????-
???? ????????? ???? ??????, ? ???? ???????
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?????????? ????????? ?????? ???????????? ? ??-
???????? ????????? ???????, ? ????????? ???-
???????? ???????? ? ???????? ?????????????.
???? ?????? ???????? ? ?????????? ????? ????
??? ?????? ????????? «??????????» ??????? ???
????????????? ??????????? ? ????????????? ??-
?????? ????. ????? ??? ??????? ???????????? ??
????????? ??????, ??? ???? ???????? ? ??????-
?????, ???????????, ?? ????????? ????????? ?
??????? ??? ??????? ??????? ?????????
?????????? ?????? ? ????????????? GOLD, 2011, 
???? ????????? ????????? (? = 0,182). ? ??? ??
??? ??????, ??? ???????? ???? ?????? ?????????
(? ?? D), ????????? ?????????? (? = 0,013) ????-
??, ??? ????????????? ? ???????????? ???-
??????? ???????? ??????? (? ?? ?). ????????
?????????? ???????? ?????? ?? ??????? ??????
????????? ?????????? ?? ???? ???????????
????????? ???????????? ?????????? ?? ???????
?????????? ????????? ??????, ??????? ????????
??????????????, ?? ????? ???? ?????????? ??-
?????? ???? ????????? ?? ?????? ?????. ??? ?????
???? ????????? ????????? ????????? ? ??? ??
????? ???????? ???????????? ?????????? ?
?????? ? ???? (???.).







? ?? ??? ?V
????????? ?????? ?? ???? ? ?????? ???????? ???????????? ?????????? ? ?????? A, B, C, D  
?????? ? ?????????? ??????, ?????????
(? = 0,003) ????????? ?????? ? ?????? ???????-
???? (7 ????) ????????? ???????? ?? ????? ?,
????? ???? ?????????? ?????? ???? ??? ??????
?? ????'?????? ?????. ???? ???? ?? ?????? ?
???????????? ??????????? ? ??????? ??? ???
??????? ???????? ????????????, ???? ??? ???-
??????? ?? ????? ?. ? ???? ?????? ?????? ?
??????? ??????????? ????????? ?????????? ??-
???????? (? < 0,001) ?????????? ???????? ? ??-
?????? ??????????? (27 ???? (79,41±6,93 % ???
????????? ?????? ? ?????) ???????? ?? ????????? ?
?? 16 ???? (94,12±5,71 % ??? ????????? ?????? ?
?????) – ?? ????????? ?, ? = 0,173), ?? ????
????????? ??? ?????????, ??? ?????? ???????????
???????? ????? ?.
???? ???? ????????????? ????, ?? ??? ?????-
??? ???????? ?????????? ????????? ?????? ??????
?????? ????????? ?????? ?? ????????? ????????
????????? ???????, ?? ???????? ??? ?????? ??-
???????? ? ???? ??????? ??????????? ??? ????-
????? ????????? ?? ???????? ????????. ??? ??
???????? ???? ???? ???????? ??? ??????? ?????????
?????????? ????????? ?? ????????? ? ???????
??????? ????????? ??????????. ???, ????? ?
?????? ???? ???????? ?????????? ???????????
????????? ?????? ?????? ???????? (6 ????
(50,00±14,43 %)) ??? ???, ??? ??? ?????????? ??
????? ?, ?, ?????? ? ????? «??????» ????? D ????
???????? ?? ???? ?????????????? (5 ??????
(10,20±4,32 %)). ????, ???????? ???? ????????-
????? ????????? ?????????? ?????? ????????-
????? ????? ? ???’????? ?????? ? ????????
???????????? ???????????. ???? ?????????, ??,
?? ??????? ??? ???? ????? ????, ????? ?????????,
??? ???? ????????? ?? ????????? D, ??????????
(? = 0,009) ?????????? ????? ? ?????? ???????-
??? ??????????? ?????? (n = 31, (63,27±6,89 %)). 
? ????? ? ????? ????????? ???? 3 (25,00±12,50 %). 
????? ? ?V ???????? ????????? ??????????? ??-
??????? ?????? ???? ?? ? ????? ? (n = 3, 
(25,00±12,50 %)), ??? ? ????? ????, ??? ???? ???-
?????? ?? ????? D (n = 13, (26,53±6,31 %)). ???-
???, ????? ???? ? ??????? ??????? ??????????
???????? ????????
??????? ???????????40
???? ????? ? ???? ?????? ??????????? ????-
????? ????????? ??????, ????????? ??? ????, ??
???? ????????? (? ?? D) ???? ????????. ?????
?????, ?????? ?????? (50,00±14,43 % ????????)
?????? ?????????? ??????? ????? ? ? ??????
??????? (10,20±4,32 %) ???????? ?? ????? D ??
?? ???????? ????????????????, ? ?? ????????? ??-
???????? ???????? ???????? ????. ???? ???
?????????? ????????? ?????????? ??????????
????????? ???????????? ???? ????????? ???-
??????????? ??????.
????? ????????? ????????? ??????????, ??
??????? ??????????? ? ???????????????? ??-
????????????? ??????, ??? ???????? ?? ??????
???? ?????? ????????? ?????????? (????. 2).
? ? ? ? ? ? ?  2  
??????????????? ???? ?????? ?? ????, ??? ???????? ?? ?????? ????
????????? ?(n = 34) 
?
(n = 17) 
?
(n = 12) 
D
(n = 49) 
?????:
1) ????????, n (?±m %) 

















































? ?????????, ??? ???????? ?? ?????? ????, ??
???? ??????????? ???????? ???????????? ??
????? (? = 0,310) ?? ??????? (? = 0,773). ????
????? ????? D ???? ???? ????? ???? ???? ??
???, ???? ??????????? ????? ?? ???? ?????-
??????? (? = 0,496 ?? ? = 0,479 ??????????). ?????
?????? ???? ?? ???????????? ?? ?????? ?????-
??????? (? = 0,054). ? ?????? ? ???? ????????
???????? ????????? ?????????. ??? ???? ???-
????? ????? ??? ????????? ????????? (? > 0,05) 
? ???? ?????????? ??????. ????? ???????????????
?????????????? ?? ???? ???’????? ? ???, ?? ????
????????? ???????? ?????. ????? ?????, ??
???????? ? ?????? ???????? ?????????? ?????????
??????, ??? ? ????????, ??? ???????? ?? ??????
????, ? ??????????? ?? ???????, ?????, ??? ??
?????? ????????????. ????? ??? ???????? ???-
??? ? ??????????? ???? ??????? ?????????
??????????? ?????? ???????????? ??????????? ??
????????? ????? ?? ????? ? ?????? ? ?????? ??
???????? ?????????. ? ??? ?? ??? ??? ???-
????????? ????????? ?????? ? ?????????????
GOLD, 2011, ??? ????? ????????? ????????? ?????
? ?? ??????, ? ?? ?????.
????????
1. ????????????, ?? ??????????? ????? ??
???? – ?? ?????????? ????? ?????????, ? ????
????????? ????????? ????? ? ???????? (48,22 %) 
? ?????? (30,36 %) ??????????? ?????????
??????.
2. ?????????? ?? ?????????? ????????? ????-
????? ????????? ????? ???????????? ??????,
???????????, ?? ???????? ????? ??????????
(? = 0,002) ????? ????? ????????? ? ?????? ??
???????? ??????????? (22,58±5,31%) ?????????
? ??????? ? ?????? ??? ???? ?????? ????????
????????? ??????????? ?????? ? ?????????
?????? (6,00±3,36%). ??? ???? ????? ? ??????
?? ???? ?????? ??????????? ? ??????????
????????? (? = 0,024). ? ??? ?? ??? ??? ?????-
??????? ????????? ?????? ? ?????????????
GOLD, 2011, ??? ????? ?? ????????????? ??
?????? ? ???????????????? ??????????, ? ????
????? ??? ?? ??????, ??? ?? ?????.
3. ???????? ?????? ?? ??????? ?????? ???-
?????? ?????????? ?????? ? ????????? GOLD, 2011 
?? ??????? ? 555 ??? ??????? ??? 27 ??????
2013 ???? ?? ? ??????????? ????????? ????????
?????????? ?? ??????? ?????????? ?????????
??????. ?????? ?????? (50,00±14,43 % ????????)
??????? ?????????? ????? ? ? ?????? ???????
(10,20±4,32 %) ???????? ?? ????? D ?? ?? ?????-
??? ????????????????, ? ?? ????????? ??????????
???????? ???????? ????. ???? ? ?????????
???????????? ?????????? ????????? ??????????-
?? ???? ????????? ?????????????? ??????.
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?????? ??????????
1. ??????????????? ?????? ??????????? ???????
??????????? ??????? ??? ????????????? ??????-
????????? ???????: ?????. ???????????? / ?.?.???-
?????, ?.?. ??????????????-?????????, ?.?. ?????-
??, ?. ?. ?????????. – ???????, 2000. – 36 ?.
2. ????? ?.?. ?????????????? ?????? ? ??????-
????????????? ????????????? ? ?????????????? Exel 
/ ?.?. ?????, ?.?. ???????, ?. ?. ?????. – ?.:??????,
2000. – 320 ?.
3. ??? ???????????? ????????? ?????????? ??-
????? ???????? ???????? ?? ????????????? "??????-
???????": ????? ??? ??????? ?555 ??? 27.06.2013 ?. / 
???????????? ??????? ??????’? ???????. ????. ???. – 
?., 2013. – 3 ?.
4. ??????? ?.?. ?????????????? ?????? ????-
??????? ??????. ?????????? ?????? ??????????
???????? STATISTICA / ?.?. ???????. – ?.: ??-
????????, 2002. – 312 ?.
5. ??????? ?.?. ????? ???????? ??????????
?????????? ?? ???? / ?.?. ??????? // ???. ????-
?????. ??????. – 2012. – ? 2. – ?. 6–8. 
6. Burgel P.-R. Identification of Clinical Phenotypes 
Using Cluster Analyses in COPD Patients with Multiple 
Comorbidities [Electronic Resource] / Pierre-Régis Bur-
gel, Jean-Louis Paillasseur, and Nicolas Roche // Hindawi 
Publishing Corporation BioMed Research International. – 
2014. – Article ID 420134, 9 pages. – ????? ??????? : 
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